retatrutide trial news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. Dr. LaPook explains it’s doing much more than what current medications can Lilly's 'triple G' retatrutide aces

Description

As of 2024, retatrutide has not received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)

A Quick Reminder Before You Head Off When it comes down to it, travelling with a GLP-1 is really about a handful of sensible habits applied consistently

This means that its natural effect in the joint is likely to be limited

(Note: for the most part, data also showed an improvement in quality of sleep and, according to FitBit, "for those whose quality of sleep has improved, they have been spending more time in deep and REM sleep.") Explanation 2: Anxiety or Stress Due to Novel Coronavirus Stress could very well be a factor, the experts we spoke to said

(Study: Akkermansia muciniphila and metabolic health during a dietary intervention Gut , BMJ) GLP-1 Medications vs Microbiome Regulation They are not substitutes